GENETICALLY DETERMINED IMMUNE HYPERREACTIVITY IN HUMAN LIVER-DISEASE

被引：11

作者：

EDDLESTON, ALWF ^{[1
]}

机构：

[1] UNIV LONDON,KINGS COLL HOSP & MED SCH,LIVER UNIT,LONDON SE5,ENGLAND

来源：

PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON | 1977年 / 70卷 / 08期

关键词：

D O I：

10.1177/003591577707000804

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：525 / 529

页数：5

共 22 条

[1]

ALLISON AC, 1971, LANCET, V2, P135

[2]

BACH JF, 1975, LANCET, V2, P707

[3]

Benacerraf B., 1975, Immunogenetics and immunodeficiency., P117

[4]

COCHRANE AMG, 1976, LANCET, V1, P441

[5] HL-A SYSTEM AND DIABETES-MELLITUS [J].

CUDWORTH, AG ;

WOODROW, JC .

DIABETES, 1975, 24 (04) :345-349

[6] INCREASED INCIDENCE OF HL-A 1 AND 8 IN PATIENTS SHOWING IGG OR COMPLEMENT COATING ON THEIR RED-CELLS [J].

DACOSTA, JAG ;

WHITE, AG ;

PARKER, AC ;

GRIGOR, GB .

JOURNAL OF CLINICAL PATHOLOGY, 1974, 27 (05) :353-355

[7]

EDDLESTON ALW, 1974, LANCET, V2, P1543

[8] HIGH PREVALENCE OF SEROIMMUNOLOGIC ABNORMALITIES IN RELATIVES OF PATIENTS WITH ACTIVE CHRONIC HEPATITIS OR PRIMARY BILIARY-CIRRHOSIS [J].

GALBRAITH, RM ;

SMITH, M ;

MACKENZIE, RM ;

TEE, DE ;

DONIACH, D ;

WILLIAMS, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (02) :63-69

[9]

GALBRAITH RM, 1976, LANCET, V1, P930

[10]

GEBHARD RL, 1973, LANCET, V2, P760

← 1 2 3 →